Sign Up
Stories
ABIO ARCA Revenue Analysis
Share
ADR Surge and Drops in NY
ARCA Biopharma Revenue Insights
Akari Therapeutics: Merger and Progress
ARCA Biopharma Revenue Insights
Amgen's Weight-Loss Drugs Market Entranc...
Analyst Recommendations Impact Diverse C...
Overview
API
ABIO ARCA biopharma's revenue breakdown highlights Callida's revenue of $612K and Nuvelo's revenue of $54K. The stock's P/E ratio stands at 14.50, accompanied by a dividend yield of 5.14%.
Ask a question
How does the P/E ratio and dividend yield influence investor decisions regarding ABIO ARCA stock?
How might the revenue breakdown impact ABIO ARCA biopharma's future strategies?
What factors contribute to the differences in revenue between Callida and Nuvelo?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Dec 2023
Jan 2024
Feb 2024
Coverage
moomo